GALLEGGIANTE, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 155
EU - Europa 80
AS - Asia 46
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 286
Nazione #
US - Stati Uniti d'America 155
CN - Cina 19
RU - Federazione Russa 17
SG - Singapore 17
DE - Germania 15
IT - Italia 9
UA - Ucraina 8
SE - Svezia 7
IE - Irlanda 6
CZ - Repubblica Ceca 5
GB - Regno Unito 4
GR - Grecia 4
KR - Corea 4
TR - Turchia 4
BR - Brasile 2
FR - Francia 2
ZA - Sudafrica 2
AU - Australia 1
BD - Bangladesh 1
FI - Finlandia 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
Totale 286
Città #
Chandler 35
Ann Arbor 22
Princeton 19
Woodbridge 15
Jacksonville 10
Singapore 8
Aresing 6
Dublin 6
Brno 5
Wilmington 5
Andover 4
Ashburn 4
Boardman 4
Izmir 4
Munich 4
Salerno 4
Dearborn 3
Redwood City 3
Shenyang 3
Beijing 2
Fairfield 2
Moscow 2
Nanjing 2
Pellezzano 2
The Dalles 2
Contagem 1
Dallas 1
Dhaka 1
Falkenstein 1
Groningen 1
Guangzhou 1
Houston 1
Johannesburg 1
Londrina 1
Mount Vernon 1
Nanchang 1
Napoli 1
New York 1
Nuremberg 1
Nürnberg 1
Quezon City 1
Rome 1
San Diego 1
Stockholm 1
Turku 1
Xiaogan 1
Zhengzhou 1
Totale 198
Nome #
Secretory leukoprotease inhibitor (Slpi) expression is required for educating murine dendritic cells inflammatory response following quercetin exposure 81
Dendritic cells modulate iron homeostasis and inflammatory abilities following quercetin exposure 67
Secretory leukoprotease inhibitor is required for efficient quercetin-mediated suppression of TNFalfa secretion 56
TNFα deficiency results in increased IL-1β in an early onset of spontaneous murine colitis 52
Quercetin-Induced miR-369-3p Suppresses Chronic Inflammatory Response Targeting C/EBP-β 40
Totale 296
Categoria #
all - tutte 1.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.501


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 1 0 2 0 3 4 6 0 6 8 2 8
2021/202229 0 0 0 0 0 1 0 2 4 4 4 14
2022/202364 6 8 1 8 12 9 0 5 6 0 2 7
2023/202417 2 1 1 0 1 2 1 0 0 2 0 7
2024/202563 8 0 0 1 5 9 14 1 8 3 10 4
Totale 296